Abdel Rasheed NO, Ibrahim WW (2022) Telmisartan neuroprotective effects in 3-nitropropionic acid Huntington’s disease model in rats: cross talk between PPAR-γ and PI3K/Akt/GSK-3β pathway. Life Sci 297:120480. https://doi.org/10.1016/j.lfs.2022.120480
Article PubMed CAS Google Scholar
Armada-moreira A, Gomes JI, Pina CC, Savchak OK, Gonçalves-ribeiro J, Rei N, Pinto S, Crunelli V, Vaz SH (2020) Going the extra (synaptic ) mile : excitotoxicity as the road toward neurodegenerative diseases. 14(April):1–27. https://doi.org/10.3389/fncel.2020.00090
Armstrong R (2020) What causes neurodegenerative disease? Folia Neuropathol 58(2):93–112. https://doi.org/10.5114/FN.2020.96707
Bai X, Pei R, Lei W, Zhao M, Zhang J, Tian L, Shang J (2020) Antidiabetic effect of artemether in Db/Db mice involves regulation of AMPK and PI3K/Akt pathways. Front Endocrinol 11(September):1–9. https://doi.org/10.3389/fendo.2020.568864
Binh TQ, Ilett KF, Batty KT, Davis TME, Hung NC, Powell SM, Thu LTA, Van Thien H, Phuöng HL, Phuong VDB (2001) Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with Falciparum malaria. Br J Clin Pharmacol 51(6):541–546. https://doi.org/10.1046/j.1365-2125.2001.01395.x
Article PubMed PubMed Central CAS Google Scholar
Bonelli RM, Wenning GK, Kapfhammer HP (2004) Huntington’s disease: present treatments and future therapeutic modalities. Int Clin Psychopharmacol 19(2):51–62. https://doi.org/10.1097/00004850-200403000-00001
Borstnik K, Paik I, Posner G (2005) Malaria: new chemotherapeutic peroxide drugs. Mini-Rev Med Chem 2(6):573–583. https://doi.org/10.2174/1389557023405620
Chen S, Wu L, He B, Zhou G, Xu Y, Zhu G, Xie J, Chen S (2021) Artemisinin facilitates motor function recovery by enhancing motoneuronal survival and axonal remyelination in rats following brachial plexus root avulsion.https://doi.org/10.1021/acschemneuro.1c00120
De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV (2012) Alzheimer’s disease. pp 329–352. https://doi.org/10.1007/978-94-007-5416-4_14
Dobson R, Giovannoni G (2019) Multiple sclerosis – a review. Eur J Neurol 26(1):27–40. https://doi.org/10.1111/ene.13819
Article PubMed CAS Google Scholar
Fan S, Zhang D, Liu F, Yang Y, Xu H (2020) Artesunate alleviates myocardial ischemia/reperfusion-induced myocardial necrosis in rats and hypoxia/reoxygenation-induced apoptosis in H9C2 cells via regulating the FAK/PI3K/Akt pathway. Ann Translat Med 8(20):1291–1291. https://doi.org/10.21037/atm-20-5182
Gao Y, Cui M, Zhong S, Feng C, Nwobodo AK, Chen B, Song Y, Wang Y (2020) Dihydroartemisinin ameliorates LPS-induced neuroinflammation by inhibiting the PI3K / AKT pathway. :661–672
Gautam A, Ahmed T, Paliwal J, Batra V (2009) Pharmacokinetics and Pharmacodynamics of endoperoxide antimalarials. Curr Drug Metab 10(3):289–306. https://doi.org/10.2174/138920009787846323
Article PubMed CAS Google Scholar
Guo F, Liu X, Cai H, Le W (2018) Autophagy in neurodegenerative diseases: pathogenesis and therapy. Brain Pathol 28(1):3–13. https://doi.org/10.1111/bpa.12545
Article PubMed CAS Google Scholar
Hauser SL, Cree BAC (2020) Treatment of multiple sclerosis : a review. Am J Med. https://doi.org/10.1016/j.amjmed.2020.05.049
Article PubMed PubMed Central Google Scholar
Hemmings BA, Restuccia DF (2012) PI3K-PKB/Akt pathway. Cold Spring Harb Perspect Med 4(9):1–4
Ho WE, Peh HY, Chan TK, Wong WSF (2014) Artemisinins: pharmacological actions beyond anti-malarial. Pharmacol Ther 142(1):126–139. https://doi.org/10.1016/j.pharmthera.2013.12.001
Article PubMed CAS Google Scholar
Illarioshkin SN, Klyushnikov SA, Vigont VA, Seliverstov YA, Kaznacheyeva EV (2018) Molecular pathogenesis in Huntington’s disease. Biochemistry (moscow) 83(9):1030–1039. https://doi.org/10.1134/S0006297918090043
Article PubMed CAS Google Scholar
Jabbarzadeh P, Salimian F, Aghapour S, Xiang S (2020) Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer – a comprehensive review from chemotherapy to immunotherapy. 156(April). https://doi.org/10.1016/j.phrs.2020.104806
Jamwal S, Singh S, Kaur N, Kumar P (2015) Protective effect of spermidine against excitotoxic neuronal death induced by quinolinic acid in rats: possible neurotransmitters and neuroinflammatory mechanism. Neurotox Res 28(2):171–184. https://doi.org/10.1007/s12640-015-9535-y
Article PubMed CAS Google Scholar
Jean S, Kiger AA (2014) Classes of phosphoinositide 3-kinases at a glance. :923–928. https://doi.org/10.1242/jcs.093773
Ji Y, Wang D, Zhang B, Lu H (2019) Bergenin ameliorates MPTP-induced Parkinson’s disease by activating PI3K/Akt signaling pathway. J Alzheim Dis. https://doi.org/10.3233/JAD-190870
Kim GH, Kim JE, Rhie SJ, Yoon S (2015) The role of oxidative stress in neurodegenerative diseases. 24(4):325–340.https://doi.org/10.5607/en.2015.24.4.325
Kiss E, Kins S, Zöller Y, Schilling S, Gorgas K, Groß D, Schlicksupp A, Rosner R, Kirsch J, Kuhse J (2021) Artesunate restores the levels of inhibitory synapse proteins and reduces amyloid-β and C-terminal fragments (CTFs) of the amyloid precursor protein in an AD-mouse model. Mol Cell Neurosci 113(June):1–5. https://doi.org/10.1016/j.mcn.2021.103624
Kovacs GG (2019) Molecular pathology of neurodegenerative diseases: principles and practice. J Clin Pathol 72(11):725–735. https://doi.org/10.1136/jclinpath-2019-205952
Article PubMed CAS Google Scholar
Kumar P, Kumar A (2009) Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington’s disease like symptoms: possible behavioural, biochemical and cellular alterations. Eur J Pharmacol 615(1–3):91–101. https://doi.org/10.1016/j.ejphar.2009.04.058
Article PubMed CAS Google Scholar
Lassmann H (2013) Pathology and disease mechanisms in different stages of multiple sclerosis. J Neurol Sci 333(1–2):1–4. https://doi.org/10.1016/j.jns.2013.05.010
Article PubMed CAS Google Scholar
Leray E, Yaouanq J, Le Page E, Coustans M, Laplaud D, Oger J, Edan G (2010) Evidence for a two-stage disability progression in multiple sclerosis. Brain 133(7):1900–1913. https://doi.org/10.1093/brain/awq076
Article PubMed PubMed Central Google Scholar
Li S, Zhao X, Lazarovici P, Zheng W (2019) Artemether Activation of AMPK/GSK3β(ser9)/Nrf2 Signaling Confers Neuroprotection towards β-Amyloid-Induced Neurotoxicity in 3xTg Alzheimer’s Mouse Model. Oxid Med Cell Longev 1862437. https://doi.org/10.1155/2019/1862437
Lin SP, Li W, Winters A, Liu R, Yang SH (2018) Artemisinin prevents glutamate-induced neuronal cell death via Akt pathway activation. Front Cell Neurosci 12(April):1–9. https://doi.org/10.3389/fncel.2018.00108
Lin S, Wei J, Hu J, Bu J, Zhu L, Li Q, Liao H, Lin P, Ye S, Chen S, Chen X (2021) Artemisinin improves neurocognitive de fi cits associated with sepsis by activating the AMPK axis in microglia. September 2020. https://doi.org/10.1038/s41401-021-00634-3
Liu L, Zhao X, Silva M, Li S, Xing X, Zheng W (2020) Artemisinin protects motoneurons against axotomy-induced apoptosis through activation of the PKA-Akt signaling pathway and promotes neural stem/progenitor cells differentiation into NeuN + neurons. Pharmacol Res 159(April):105049. https://doi.org/10.1016/j.phrs.2020.105049
Article PubMed CAS Google Scholar
Liu Z, Ren Z, Zhang J, Chuang C (2018) Role of ROS and nutritional antioxidants in human diseases. 9(May):1–14.https://doi.org/10.3389/fphys.2018.00477
Liu Y, Dang W, Zhang S (2021) Artesunate attenuates inflammatory injury and inhibits the NF-k B pathway in a mouse model of cerebral ischemia.https://doi.org/10.1177/03000605211053549
Long H, Cheng Y, Zhou Z, Luo H, Wen D (2021) PI3K/AKT signal pathway : a target of natural products in the prevention and treatment of Alzheimer’s disease and Parkinson’s disease. 12(April):1–20. https://doi.org/10.3389/fphar.2021.648636
Lu BW, Baum L, So KF, Chiu K, Xie LK (2019) More than anti-malarial agents: therapeutic potential of artemisinins in neurodegeneration. Neural Regen Res 14(9):1494–1498. https://doi.org/10.4103/1673-5374.255960
Article PubMed PubMed Central CAS Google Scholar
Ma Z, Woon CY-N, Liu C-G, Cheng J-T, You M, Sethi G, Wong AL-A, Ho PC-L, Zhang D, Ong P, Wang L, Goh B-C (2021) Repurposing artemisinin and its derivatives as anticancer drugs: a chance or challenge? Front Pharmacol 12(December):1–26. https://doi.org/10.3389/fphar.2021.828856
Manning BD, Toker A (2017) Review AKT/PKB signaling : navigating the network. Cell 169(3):381–405. https://doi.org/10.1016/j.cell.2017.04.001
Article PubMed PubMed Central CAS Google Scholar
Matsuda S, Ikeda Y, Murakami M, Nakagawa Y, Tsuji A, Kitagishi Y (2019) Roles of PI3K/AKT/GSK3 pathway involved in psychiatric illnesses. Diseases 7(1):22. https://doi.org/10.3390/diseases7010022
Article PubMed PubMed Central CAS Google Scholar
Navaratnam V, Mansor SM, Sit NW, Grace J, Li Q, Olliaro P (2000) Pharmacokinetics of artemisinin-type compounds. Clin Pharmacokinet 39(4):255–270. https://doi.org/10.2165/00003088-200039040-00002
Article PubMed CAS Google Scholar
Newton PN, Van Vugt M, Teja-Isavadharm P, Siriyanonda D, Rasameesoroj M, Teerapong P, Ruangveerayuth R, Slight T, Nosten F, Suputtamongkol Y, Looareesuwan S, White NJ (2002) Comparison of oral artesunate and dihydroartemisinin antimalarial bioavailabilities in acute falciparum malaria. Antimicrob Agents Chemother 46(4):1125–1127. https://doi.org/10.1128/AAC.46.4.1125-1127.2002
Article PubMed PubMed Central CAS Google Scholar
Nitulescu GM, Margina D, Juzenas P, Peng Q, Spandidos DΑ, Libra M, Tsatsakis AM (2016) Akt inhibitors in cancer treatment : the long journey from drug discovery to clinical use (Review). 869–885. https://doi.org/10.3892/ijo.2015.3306
Ojeda L, Gao J, Hooten KG, Wang E, Thonhoff JR, Dunn TJ, Gao T, Wu P (2011) Critical role of PI3K/Akt/GSK3β in motoneuron specification from human neural stem cells in response to FGF2 and EGF. PLoS ONE 6(8):e23414. https://doi.org/10.1371/journal.pone.0023414
Article PubMed PubMed Central CAS Google Scholar
Okorji UP, Velagapudi R, El-Bakoush A, Fiebich BL, Olajide OA (2016) Antimalarial drug artemether inhibits neuroinflammation in BV2 microglia through Nrf2-dependent mechanisms. Mol Neurobiol 53(9):6426–6443. https://doi.org/10.1007/s12035-015-9543-1
Article PubMed CAS Google Scholar
Okorji UP, Velagapudi R, El-bakoush A (2015) Antimalarial drug artemether inhibits neuroinflammation in BV2 microglia through Nrf2-dependent mechanisms. https://doi.org/10.1007/s12035-015-9543-1
Olanow CW, Stern MB, Sethi K (2009) The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology 72(21 SUPPL 4). https://doi.org/10.1212/WNL.0b013e3181a1d44c
Peden AH, Ironside JW (2012) Molecular pathology in neurodegenerative diseases. Curr Drug Targets 13(12):1548–1559. https://doi.org/10.2174/138945012803530134
Article PubMed CAS Google Scholar
Peltier J, O’Neill A, Schaffer DV (2007) PI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation. Dev Neurobiol 67(10):1348–1361. https://doi.org/10.1002/dneu.20506
留言 (0)